ATV-1601

N/A

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameATV-1601
Drug Alias NameATV-1601
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsSolid tumoursBreast DiseasesTelangiectasia, Hereditary Hemorrhagic +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeFrance +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtavistik Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtavistik Bio Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursTelangiectasia, Hereditary HemorrhagicProstatic Neoplasms +[14] 
Inactive IndicationsBreast DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A